Pharmaceutical Quality and Practices

Step-by-Step Risk Assessment Process in QbD Stability Testing

Posted on By

A robust, step-by-step risk assessment process enables proactive quality by design. By applying tools like FMEA, assigning clear scores, and building effective mitigation and control strategies, pharma professionals can enhance the scientific foundation of their stability testing protocols. This approach not only improves regulatory success but supports long-term lifecycle management and product reliability.
Click to read the full article.

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing

ICH Q8 Guidelines for QbD-Based Stability Design

Posted on By

Applying ICH Q8 to stability testing fosters a scientific, lifecycle-focused, and globally harmonized approach. By connecting QTPP, CQA, risk assessment, and control strategies, pharma teams can create protocols that are not only regulatory-friendly but also adaptable and future-proof. This is the essence of QbD — building quality into the product rather than testing it at the end.
Click to read the full article.

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing

Using Design of Experiments (DoE) for Stability Optimization

Posted on By

The concept of design space is central to ICH Q8 — it represents the multidimensional combination of input variables that provide assurance of quality. DoE allows you to mathematically define this space by pinpointing the acceptable range for critical factors such as temperature, humidity, or formulation pH that ensures product stability.
Click to read the full article.

Pharmaceutical Quality and Practices, Quality by Design (QbD) in Stability Testing